FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803139388> ?p ?o ?g. }

• W2803139388 endingPage "1790" @default.
• W2803139388 startingPage "1780" @default.
• W2803139388 abstract "Chronic idiopathic inflammatory bowel disease (IBD) is a significant risk factor for the development of intestinal adenocarcinoma. The underlying molecular alterations in IBD-associated intestinal adenocarcinoma remain largely unknown. We compared the clinicopathologic and molecular features of 35 patients with 47 IBD-associated intestinal adenocarcinomas with a consecutive series of 451 patients with sporadic colorectal carcinoma identified at our institution and published data on sporadic colorectal carcinoma. c-MYC amplification was the most frequent molecular alteration identified in 33% of IBD-associated intestinal adenocarcinoma that is a significantly higher frequency than in sporadic colorectal carcinoma (8%) (P = 0.0001). Compared to sporadic colorectal carcinoma, IBD-associated intestinal adenocarcinomas more frequently demonstrated mucinous differentiation (60% vs 25%, P < 0.001) and signet ring cell differentiation (28% vs 4%, P < 0.001). Mucinous and signet ring cell differentiation were significantly associated with the presence of c-MYC amplification (both with P < 0.05). HER2 positivity (11%), KRAS exon 2 or 3 mutation (10%), and IDH1 mutation (7%) were less commonly observed in IBD-associated intestinal adenocarcinoma. There was an association between poor survival and HER2 status with 3 of 4 patients having HER2-positive adenocarcinoma dead of disease at last clinical follow-up; however, no statistically significant survival effect was identified for any of the molecular alterations identified. We demonstrate that IBD-associated intestinal adenocarcinomas have a high frequency of c-MYC amplification that is associated with mucinous and signet ring cell differentiation. Many of the identified molecular alterations have potential therapeutic relevance, including HER2 amplification, IDH1 mutation, and low frequency KRAS mutation." @default.
• W2803139388 created "2018-06-01" @default.
• W2803139388 creator A5002303350 @default.
• W2803139388 creator A5015029502 @default.
• W2803139388 creator A5022105097 @default.
• W2803139388 creator A5024731955 @default.
• W2803139388 creator A5040612375 @default.
• W2803139388 creator A5053335528 @default.
• W2803139388 date "2018-05-17" @default.
• W2803139388 modified "2023-10-15" @default.
• W2803139388 title "Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation" @default.
• W2803139388 cites W1487867498 @default.
• W2803139388 cites W1540575218 @default.
• W2803139388 cites W1938145277 @default.
• W2803139388 cites W1967123206 @default.
• W2803139388 cites W1968899624 @default.
• W2803139388 cites W1981086388 @default.
• W2803139388 cites W1998516458 @default.
• W2803139388 cites W2014776577 @default.
• W2803139388 cites W2025810798 @default.
• W2803139388 cites W2034147960 @default.
• W2803139388 cites W2037856457 @default.
• W2803139388 cites W2049366788 @default.
• W2803139388 cites W2058317300 @default.
• W2803139388 cites W2062348957 @default.
• W2803139388 cites W2071036685 @default.
• W2803139388 cites W2071370702 @default.
• W2803139388 cites W2093332642 @default.
• W2803139388 cites W2093690138 @default.
• W2803139388 cites W2099467873 @default.
• W2803139388 cites W2099954087 @default.
• W2803139388 cites W2117277249 @default.
• W2803139388 cites W2142055693 @default.
• W2803139388 cites W2155507705 @default.
• W2803139388 cites W2158930367 @default.
• W2803139388 cites W2197459376 @default.
• W2803139388 cites W2200646757 @default.
• W2803139388 cites W2262414037 @default.
• W2803139388 cites W2305307972 @default.
• W2803139388 cites W2321327051 @default.
• W2803139388 cites W2336815607 @default.
• W2803139388 cites W2342934617 @default.
• W2803139388 cites W2405694263 @default.
• W2803139388 cites W2463552590 @default.
• W2803139388 cites W2490911793 @default.
• W2803139388 cites W2590867271 @default.
• W2803139388 cites W2620163964 @default.
• W2803139388 cites W2730859216 @default.
• W2803139388 cites W3083236858 @default.
• W2803139388 doi "https://doi.org/10.1093/ibd/izy057" @default.
• W2803139388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29788391" @default.
• W2803139388 hasPublicationYear "2018" @default.
• W2803139388 type Work @default.
• W2803139388 sameAs 2803139388 @default.
• W2803139388 citedByCount "12" @default.
• W2803139388 countsByYear W28031393882019 @default.
• W2803139388 countsByYear W28031393882020 @default.
• W2803139388 countsByYear W28031393882021 @default.
• W2803139388 countsByYear W28031393882022 @default.
• W2803139388 countsByYear W28031393882023 @default.
• W2803139388 crossrefType "journal-article" @default.
• W2803139388 hasAuthorship W2803139388A5002303350 @default.
• W2803139388 hasAuthorship W2803139388A5015029502 @default.
• W2803139388 hasAuthorship W2803139388A5022105097 @default.
• W2803139388 hasAuthorship W2803139388A5024731955 @default.
• W2803139388 hasAuthorship W2803139388A5040612375 @default.
• W2803139388 hasAuthorship W2803139388A5053335528 @default.
• W2803139388 hasConcept C121608353 @default.
• W2803139388 hasConcept C126322002 @default.
• W2803139388 hasConcept C142724271 @default.
• W2803139388 hasConcept C189528381 @default.
• W2803139388 hasConcept C2778260677 @default.
• W2803139388 hasConcept C2779134260 @default.
• W2803139388 hasConcept C2780238495 @default.
• W2803139388 hasConcept C2781182431 @default.
• W2803139388 hasConcept C2781187634 @default.
• W2803139388 hasConcept C502942594 @default.
• W2803139388 hasConcept C526805850 @default.
• W2803139388 hasConcept C71924100 @default.
• W2803139388 hasConcept C90924648 @default.
• W2803139388 hasConceptScore W2803139388C121608353 @default.
• W2803139388 hasConceptScore W2803139388C126322002 @default.
• W2803139388 hasConceptScore W2803139388C142724271 @default.
• W2803139388 hasConceptScore W2803139388C189528381 @default.
• W2803139388 hasConceptScore W2803139388C2778260677 @default.
• W2803139388 hasConceptScore W2803139388C2779134260 @default.
• W2803139388 hasConceptScore W2803139388C2780238495 @default.
• W2803139388 hasConceptScore W2803139388C2781182431 @default.
• W2803139388 hasConceptScore W2803139388C2781187634 @default.
• W2803139388 hasConceptScore W2803139388C502942594 @default.
• W2803139388 hasConceptScore W2803139388C526805850 @default.
• W2803139388 hasConceptScore W2803139388C71924100 @default.
• W2803139388 hasConceptScore W2803139388C90924648 @default.
• W2803139388 hasIssue "8" @default.
• W2803139388 hasLocation W28031393881 @default.
• W2803139388 hasLocation W28031393882 @default.
• W2803139388 hasOpenAccess W2803139388 @default.
• W2803139388 hasPrimaryLocation W28031393881 @default.

• next